文献速递运动医学关节外科

距骨骨软骨损伤微骨折术后骨髓水肿的存在与程度影响中期临床结局

The Presence and Degree of Bone Marrow Edema Influence Midterm Clinical Outcomes After Microfracture for Osteochondral Lesions of the Talus.
PubMed 文献 · Am J Sports Med · 2018-07-17

该队列研究纳入2008至2013年接受微骨折治疗的距骨骨软骨损伤患者43例,于术后2年和4年评估骨髓水肿(BME)与足踝结局评分(FAOS)的关系。2年随访时BME组与无BME组FAOS无显著差异,4年随访时BME组FAOS显著低于无BME组,且BME分级与FAOS在4年随访时显著相关。作者认为短期随访BME为正常生理反应,中期随访BME可能为病理状态并与较差临床结局相关。

要点

  • 微骨折术后4年,BME组FAOS为77.5±11.1,无BME组为84.7±8.4,差异显著(P=.041)。
  • 4年随访BME分级0至3级FAOS分别为84.7±7.4、80.1±10.5、74.0±10.3、67.5±7.1,差异显著(P=.035)。
  • 4年随访74%患者仍存在软骨下BME,BME分级与FAOS显著相关(r=-0.453,P=.003)。

核心结论

  • 微骨折治疗距骨骨软骨损伤后中期随访存在软骨下BME的患者临床结局差于无BME者。
  • 中期随访软骨下BME程度与临床结局相关。
  • 短期随访时无论BME存在与否及程度如何,临床结局均无显著差异,且临床结局与BME程度无相关性。
  • 作者认为短期随访BME为正常生理反应,而中期随访BME可能为病理状态并与较差临床结局相关。

研究设计与样本

  • 队列研究,证据等级3。
  • 纳入2008至2013年间接受微骨折治疗的患者,于术后2年和4年随访评估。
  • 52例符合条件患者中43例(83%)被纳入。
  • 采用磁共振成像评估BME,以脂肪抑制T2加权序列判定软骨下BME存在。
  • 临床结局采用足踝结局评分(FAOS)评估,P<.05为有统计学显著性。

主要发现

  • 2年随访时BME组与无BME组FAOS分别为83.1±6.5与88.6±8.0,无显著差异(P=.109)。
  • 4年随访时BME组与无BME组FAOS分别为77.5±11.1与84.7±8.4,差异显著(P=.041)。
  • 4年随访BME分级0、1、2、3级FAOS分别为84.7±7.4、80.1±10.5、74.0±10.3、67.5±7.1,差异显著(P=.035)。
  • 事后分析显示0级与2级、0级与3级、1级与3级之间差异显著(P=.041、.037、.048)。
  • 4年随访FAOS与BME分级显著相关(r=-0.453,P=.003),2年随访无显著相关(r=-0.212,P=.178);4年随访时74%患者仍存在软骨下BME。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subchondral bone marrow edema (BME) has been associated with articular cartilage loss, with the potential to be a negative prognostic indicator for clinical outcomes after microfracture. However, no single study has investigated the association between BME and clinical outcomes after microfracture for osteochondral lesions of the talus (OLTs) at midterm follow-up. PURPOSE: To clarify the association between postoperative subchondral BME and clinical outcomes in patients treated with microfracture for OLTs at both short-term and midterm follow-up using a grading system that classified the extent of BME of the talus. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Patients who underwent microfracture between 2008 and 2013 were assessed at 2- and 4-year postoperative follow-up. BME was evaluated using magnetic resonance imaging, and the presence of subchondral BME was determined with fat-suppressed T2-weighted sequences. Clinical outcomes were evaluated using the Foot and Ankle Outcome Score (FAOS). P < .05 was considered to be statistically significant. RESULTS: Forty-three (83%) of 52 eligible patients were included. No significant differences were found in the FAOS between the BME and no BME groups at 2-year follow-up (83.1 ± 6.5 vs 88.6 ± 8.0, respectively; P = .109), but there was a significant difference at 4-year follow-up (77.5 ± 11.1 vs 84.7 ± 8.4, respectively; P = .041). A significant difference was found among BME grades at 4-year follow-up (grade 0: 84.7 ± 7.4, grade 1: 80.1 ± 10.5, grade 2: 74.0 ± 10.3, and grade 3: 67.5 ± 7.1; P = .035). A post hoc analysis showed significant differences between grades 0 and 2, 0 and 3, and 1 and 3 ( P = .041, .037, and .048, respectively). In addition, at 4-year follow-up, a significant correlation was noted between the FAOS and BME grade ( r = -0.453, P = .003) but not at 2-year follow-up ( r = -0.212, P = .178). Seventy-four percent of patients still had subchondral BME at 4-year follow-up after microfracture for OLTs. CONCLUSION: Patients with subchondral BME at midterm follow-up after microfracture for OLTs had worse clinical outcomes than those without subchondral BME. In addition, the degree of subchondral BME at midterm follow-up was correlated with clinical outcomes. However, at short-term follow-up, there were no significant differences in clinical outcomes based on both the presence and degree of BME, and no correlation was found between clinical outcomes and the degree of BME. The current study suggests that BME at short-term follow-up is a normal physiological reaction. However, BME at midterm follow-up after microfracture for OLTs may be pathological and is associated with poorer clinical outcomes.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Shimozono Y, Hurley ET, Yasui Y, et al. The Presence and Degree of Bone Marrow Edema Influence Midterm Clinical Outcomes After Microfracture for Osteochondral Lesions of the Talus. Am J Sports Med. 2018. PMID: 30015509. doi:10.1177/0363546518782701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。